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Abstract Peroxynitrite (ONOO -) is a cytotoxic species 
formed in vivo. There is considerable interest in the development 
of ONOO" 'scavengers' as therapeutic agents; several thiols 
have been suggested to fulfil this role. One protein inactivated by 
ONOO - is ai-antiproteinase (oiiAP), the major inhibitor of 
serine proteinases in human body fluids. At low thiohONOO-
concentration ratios, several thiols (captopril, peniciUamine, 
cysteine, cystine and peniciUamine disulphide) aggravated 
inactivation of ociAP by ONOO , whereas GSH, GSSG, 
homocysteine, ergothioneine, 7V-acetylcysteine, lipoate and 
dihydrolipoate did not. We suggest that sulphur-containing 
radicals are produced by reaction of certain thiols/disulphides 
with ONOO" or ONOO--derived products and could mediate 
biological damage, including inactivation of di 4P. This must be 
considered in attempts to use thiols as 'peroxynitrite scavengers'. 
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1. Introduction 
Although the free radical gas nitric oxide (nitrogen mon-
oxide, NO') has many important physiological functions, its 
production in excess may contribute to the pathology of sev-
eral diseases [1-3]. Part of the toxicity of NO' involves its fast 
[4] reaction with 0 2 ' to give peroxynitrite, ONOO - . 
0'2" + NO'^ONOO" 
At pH 7.4, ONOO - protonates and decomposes by a series 
of complex reaction pathways: addition of ONOO - to bio-
logical systems can result in peroxidation of lipids, oxidation 
of methionine and -SH residues in proteins, depletion of anti-
oxidants, displacement of metals from metalloproteins, DNA 
oxidation and nitration, and nitration of protein tyrosine res-
idues (reviewed in [1,5,6]). 
There is therefore considerable interest in the design of 
peroxynitrite 'scavengers' for therapeutic use [3]. Peroxynitrite 
and/or its breakdown products react with many -SH com-
pounds, including GSH and peniciUamine [5,7-12], whereas 
their reactions with disulphides appear generally slower [13], 
although lipoic acid is an exception [12]. In the present paper, 
we show that certain thiols and disulphides, at low concen-
trations relative to those of ONOO - , can aggravate damage 
to a protein caused by ONOO - addition. The protein inves-
tigated is oci-antiproteinase, a physiologically important pro-
tein that is the major inhibitor of serine proteases (such as 
"■Corresponding author. Fax: (44) (171) 333 4949. 
elastase) in human body fluids. oti-Antiproteinase has already 
been shown to be inactivated upon addition of ONOO - in 
vitro [14]. cci-Antiproteinase is inactivated at sites of inflam-
mation in vivo [15], and attack by ONOO - provides a plau-
sible explanation of the inactivation of oci-antiproteinase in 
the inflamed rheumatoid joint [8]. 
2. Materials and methods 
2.1. Reagents 
JV-Succinyl (ala)3 p-nitroanilide (SANA), elastase (E0258), ai-anti-
proteinase (A9024), thiols, disulphides, D,L-tyrosine and all other re-
agents were from Sigma Chemical Corp., London, UK, except that 
lipoic and dihydrolipoic acids were a gift from Asta Medica, Ger-
many. Peroxynitrite was synthesised as described in [1]. Concentra-
tions of stock ONOO- were re-determined before each experiment at 
302 nm using a molar absorption coefficient of 1670 cm-1 M_1 [1]. 
Concentrations of 250-300 mM were usually obtained. 
2.2. Analysis of nitrotyrosine 
Nitration of tyrosine on addition of peroxynitrite was measured by 
HPLC as described in [13]. 
2.3. a¡-AntiproteÍnase inactivation 
Elastase and oti-antiproteinase (otiAP) activities were measured es-
sentially as described in [16]. otiAP was dissolved in phosphate-buf-
fered saline, pH 7.4 (140 mM NaCl, 2.7 mM KC1, 16 mM Na2HP04, 
2.9 mM KH2PO4) to a concentration of 4 mg/ml and elastase in the 
same buffer to 5 mg/ml. The volume of 04AP needed to inhibit elas-
tase 80-90% (typically 60-70 μΐ) was added to buffer (500 mM 
K2HPO4-KH2PO4 pH 7.4) with or without 0.1 ml of thiol/disulphide 
to be tested to give a volume of 0.945 ml (final ociAP concentration 
0.3 mg/ml) and incubated in a water bath at 37CC for 15 min, when 
peroxynitrite (typically 5 μΐ) was added to give a final concentration of 
0.5 mM. The sample was vortexed for 10 s and incubated for 5 min. 
Then elastase (usually 50 μΐ) was added and the mixture incubated for 
15 min. This was followed by addition of 2.0 ml of buffer and incu-
bation at 37°C for a further 15 min. Finally, 0.1 ml of elastase sub-
strate (SANA) was added and the rate of reaction followed at 410 nm 
for 30 s. A similar procedure was followed for inactivation of 04AP 
by hypochlorous acid (HOC1); αιΑΡ was incubated with HOC1 (10 
μΜ) for 60 min since under these reaction conditions the degree of 
inactivation was similar to that produced by 0.5 mM ONOO- for 
5 min incubation. HOC1 was prepared fresh before use and its con-
centration determined, both as described as in [17]. 
3. Results 
3.1. Inactivation of a¡AP by ONOO~ addition 
Addition of ONOO - to 04AP at pH 7.4 causes loss of its 
elastase-inhibitory capacity [13,14]. The reaction is complete 
within 5 min and the extent of inactivation depends upon 
peroxynitrite concentration; 0.5 mM was chosen on the basis 
of previous studies to achieve a substantial, but not complete, 
inactivation [13]. Previous studies [13] have shown that other 
constituents of the ONOO - preparation [1] do not contribute 
to the inactivation. 
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Fig. 1. Effect of various compounds on the inactivation of c*iAP by peroxynitrite in a strongly buffered solution at pH 7.4. Concentrations giv-
en on the x-axis are the final concentrations in the first reaction mixture (containing aiAP and buffer). Results are mean±S.E., « > 4 . Before 
treatment with ONOO - , the a iAP inhibited elastase by 85±4% (A). A: No effect of GSH or GSSG on inactivation; protection by lipoic acid 
and dihydrolipoate. B: Aggravation of inactivation by low concentrations of captopril, penicillamine, cysteine, cystine and penicillamine disul-
phide. The scale on the x-axis has been expanded to make the results clearer. C: No effect of homocysteine, homocystine, JV-acetylcysteine or 
ergothioneine (scale also expanded). D: Effect of some of the above compounds on the nitration of tyrosine by ONOO -
tration was shown by any compound. 
No stimulation of ni-
3.2. Aggravation of ONOO~-dependent atAP inactivation by 
certain thiols and disulphides 
Fig. 1 shows the effect of adding low concentrations of 
thiols and disulphides. Captopril , penicillamine, cysteine, cys-
tine and penicillamine disulphide reproducibly aggravated 
a i A P inactivation by O N O O - (Fig. IB). By contrast, homo-
cysteine, dihydrolipoate, ergothioneine, lipoic acid, GSH, 
GSSG and N-acetylcysteine at similar concentrations did 
not (Fig. 1A,C). Indeed, dihydrolipoate and lipoate were pro-
tective (Fig. 1A). 
Control experiments showed that none of the thiols/disul-
phides had any direct effect on elastase, or on the ability of 
cciAP to inhibit elastase, i.e. they do not interfere with the 
assay procedures. If any of the thiols or disulphides were 
added to the reaction mixture after 5 min incubation of 
04AP with O N O O " , they had no effect (Fig. 2A). Hence these 
compounds cannot alter the residual activity of a i A P after 
damage by O N O O " . Incubation of the thiols or disulphides 
with O N O O - for 5 min before adding O4AP gave no observ-
able inactivation of a i A P subsequently added (Fig. 2B), ex-
cept for a small effect in the case of penicillamine. Hence the 
products of reaction of thiols/disulphides with O N O O " that 
cause inactivation of 04 A P do not persist in the reaction mix-
ture. 
3.3. Lack of effect of thiols I disulphides on nitration of tyrosine 
by ONOO-
Addition of peroxynitrite to cells and tissues leads to nitra-
tion of tyrosine residues [1]. Hence another assay often used 
to assess peroxynitrite 'scavengers' in vitro is to examine their 
effect on tyrosine nitration [1,8,18]. N o n e of the thiols or 
disulphides at concentrations that aggravated a i A P inactiva-
tion stimulated the nitration of tyrosine. Either they had no 
effect (cystine, penicillamine disulphide) or they inhibited ty-
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rosine nitration (captopril, ergothioneine, cysteine, penicill-
amine) (Fig. ID). 
3.4. Effect of thiolsldisulphides on inactivation of a}AP 
by HOCl 
Another agent known to inhibit 04AP in vitro is HOCl [19]. 
None of the compounds that aggravated αι ΑΡ inactivation in 
the presence of ONOO" did so in the presence of HOCl: they 
either protected or had no effect (Fig. 3). Our data are con-
sistent with previous literature reports that thiols and certain 
disulphides are HOCl scavengers [17,20,21]. 
4. Discussion 
Our data show that certain thiols and disulphides at low 
concentrations can aggravate the inactivation of oiiAP upon 
addition of ONOO". By contrast, addition of any of the 
thiols (or of lipoic acid) at concentrations greater than 200 
μΜ decreased inactivation of ociAP (data not shown, as in 
agreement with previous literature reports [8,12,13]). Our data 
show the importance of testing 'scavengers' over a wide con-
centration range. 
What mechanism can account for these effects? The thiols/ 
disulphides had no direct effect on otiAP or elastase. Addition 
of them to ctiAP already inactivated by ONOO" did not 
restore or further diminish activity (Fig. 2A). Hence the effects 
must involve interaction of the thiols/disulphides with 
ONOO - or ONOO-derived species. However, any damaging 
products that result do not survive in the reaction mixture 
when ONOO" is preincubated with thiols/disulphides before 
04AP addition (Fig. 2B). 
Several thiols are known to generate thiyl and thiyl-derived 
radicals upon exposure to ONOO" [5,9-11]. It is also known 
that penicillamine-derived sulphur radicals can inactivate 
αιΑΡ [22]. It thus seems logical to propose that ONOO -
dependent formation of sulphur radicals from certain thiols/ 
disulphides is the explanation of aggravated 04AP inactiva-
tion. At higher levels of thiols/disulphides, the sulphur radi-
cals responsible may well disappear by further reactions with 
their parent compounds [23,24] rather than attacking otiAP, 
thereby accounting for loss of the aggravating effect. A mech-
anism involving sulphur radicals would also explain why no 
aggravation of HOCl-dependent inactivation of 04AP is ob-
served; reaction of HOCl with GSH (and presumably other 
thiols or disulphides) is reported not to generate free radicals 
[25]. The lack of stability of the species involved (Fig. 2B) is 
also consistent with free radical formation. 
There is growing interest in biological damage by thiyl and 
oxysulphur radicals [21,23,24,26]. For example, such radicals 
have been suggested to account for the autoimmunity often 
seen in arthritis patients treated with penicillamine [22]. If our 
proposed explanation is correct, then there must be funda-
mental differences in the ability of sulphur radicals derived 
from different thiols/disulphides to inactivate 04AP: cysteine, 
captopril, cystine, penicillamine and penicillamine disulphide 
aggravated 04AP inactivation, but GSH, ergothioneine and 
homocysteine did not. Of course, sulphur radicals are able 
to damage biological targets other than 04AP [26,27]. The 
use of oiiAP may thus represent a useful 'screen' for potential 
toxic effects of radicals derived by interaction of ONOO -
and/or ONOO"-derived species with putative 'ONOO - scav-
engers' proposed as therapeutic agents. 
499 
Fig. 2. Control experiments. A: otiAP was incubated with ONOO-
and buffer for 5 min, then thiols/disulphides were added to give a 
30 μΜ final concentration followed by a further 30 min incubation. 
None of the compounds restored or further decreased the elastase-
inhibitory capacity of ociAP. B: Peroxynitrite was incubated with 
thiols/disulphides (30 μΜ) for 5 min, then ctiAP was added fol-
lowed by a further 30 min incubation. There was no effect on the 
elastase-inhibitory capacity of 04AP, except for a small decrease in 
the case of penicillamine. Results for both panels are mean±S.E., 
« = 4. 
Another question is whether aggravation of damage to 
ociAP by this mechanism could occur in vivo. This protein 
is inactivated at sites of chronic inflammation, e.g. in the in-
flamed rheumatoid joint [15], in which ONOO - is generated 
at high levels as evidenced by measurements of nitrotyrosine 
[28] and NO¡"/NO¡" [29]. Levels of cysteine and cystine in 
human body fluids are normally in the range of 8-10 and 
90 μΜ respectively [30], and typical body fluid levels of pen-
icillamine in patients taking this drug are 20-50 μΜ [31]. 
These levels are comparable to those shown here to aggravate 
the effects of ONOO - on ociAP Of course, we have used a 
high ONOO - concentration to achieve substantial inactiva-
tion of 04AP in a short time and allow accurate measure-
ments. Aggravation of ONOO--dependent oiiAP inactivation 
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Fig. 3. Effect of various thiols/disulphides on the inactivation of a iAP by HOC1 at pH 7.4. No aggravation of inactivation by HOC1 was ob-
served by any of the thiols or disulphides mentioned in this paper. 
is still observed at lower O N O O ~ concentrations (tested down 
to 50 μΜ). Hence it might be feasible in vivo, although more 
work is needed to establish this. 
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